Evoke Pharma Highlights Positive PK Study Data & Discusses Path Toward 505(b)(2) NDA Submission

Tue, Oct 31, 2017 9:00 AM EDT

Already Registered? Log In Now

Complete this form to enter the webcast.
(* indicates required field)